The Ethics and Compliance Team offers a series of Code Information Sessions to members, non-members, and businesses/individuals working with the pharmaceutical industry anyone interested. These workshops are online, free, and available to all. Membership of Medicines Australia is not a pre-requisite to attend however there in most of the sessions there is an assumed base knowledge of the Code.
The Ethics and Compliance Team advertise these events through our communication channels including social media, and also directly to our members. Registrations open one month prior to the event. Code Information Sessions usually consist of an online presentation and allowing for questions-and-answers. The events are usually held on Thursday mornings from 10:30am – 12pm.
More information available through the Ethics and Compliance Team via email codehelpdesk@medicinesaustralia.com.au
2026 Online Program
Note: the link to register for these events will be made available on this webpage one month prior to the event.
Conversations and the Code: Compliance and Decision Making – Navigating AI and Emerging Technologies.
Thursday 24th June – 10:30am – 11:45am online.
In an era of automation, omnichannel engagement, and AI‑driven insights, decision‑making is evolving—yet accountability remains firmly human. This session examines how digital technologies, including AI, are reshaping compliance processes and influencing decision‑making across medical affairs and promotional review. We will explore emerging risks and practical lessons from real‑world adoption of AI‑enabled approaches that withstand regulatory scrutiny and ethical expectations.
This is not a usual Code Info Session – instead it is an exploration with guest speakers Andrew Weekes (Independent Consultant at InspiRx), and Mark Baxter (VP, Innovation at RxPx Inc) . Andrew, based in Melbourne, and Mark, based in British Columbia, both work closely with industry, helping organisations navigate these issues through strategic advice and AI‑enabled solutions.
Achieving Balance in Promotional Materials.
Thursday 20th August – 10:30am – 12pm online.
The Code requires companies to provide balanced, fair, and accurate information to support the appropriate use of medicines. This session explores how to achieve that balance in practice, including how to incorporate essential safety and precautionary information, when additional risk detail is needed to offset claims, and how to ensure materials align with Sections 1.1 and 2.1 of the Code.
Designed to strengthen ethical decisionmaking, the session also addresses emerging challenges such as digital PI, QR codes, and dynamic content, helping industry navigate evolving formats while maintaining compliance.
Conversations and the Code: Misinformation, Disinformation and Information Gaps in relation to Prescription Medicines.
Thursday 5th November – 10:30am – 12pm online.
The spread of misinformation, disinformation and incomplete information about prescription medicines increasingly affects patients and can undermine appropriate use and public trust. While companies must not promote prescription medicines to the general public, the Code provides limited guidance on how industry should respond when public information is inaccurate or misleading, creating a practical and ethical tension.
This session considers these challenges at a high level by exploring the concepts of misinformation, disinformation and information gaps, and discussing factors that may be taken into account when such issues emerge. It will also touch on contemporary contexts such as social and digital platforms, thirdparty commentary, media reporting and evolving sources of health information, encouraging reflection on ethical decisionmaking and alignment with the intent of the Code.
Speakers TBA
Previous Code Info Sessions
Some of the Info sessions are recorded and made available on our Code Resource Toolkit Some of these recordings are abridged version of the actual webinar, but capture key points.